BHVN Q3 2025 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$169M

Net Income

-$173M

EPS (Diluted)

$-1.64

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$146M

Free Cash Flow

-$146M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$409M

Total Liabilities

$426M

Stockholders' Equity

-$17M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$169M	-$178M	+4.9%
Net Income	-$173M	-$160M	-8.2%